Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Research Article
  • Published:

Association between the methylenetetrahydrofolate reductase 677C→T missense mutation and schizophrenia

Abstract

The schizophrenia phenotype is heterogeneous with respect to clinical presentation, long-term response to medication, and outcome, possibly reflecting genetic heterogeneity and/or the presence of modifier genes.1 Compared to non-responders, schizophrenic patients who are responders to neuroleptic medications are characterized by a high female/male ratio,2a better long-term outcome3 and more frequently disturbed dopamine neurotransmission.4 In this study, we compared two groups of schizophrenic patients selected on the basis of their long-term response to neuroleptics (excellent responders and non-responders) and a group of healthy volunteers, with regard to a missense mutation (677C→T) in the methylenetetrahydrofolate reductase (MTHFR) gene. This polymorphism was chosen because it is functional5 and was previously associated with schizophrenia.6 The present study revealed a significant association between schizophrenia and allele T of this gene. This association was entirely due to an over-representation of allele T in responder patients compared to controls; nonresponder patients did not differ from controls. Genotype TT was more frequent in responder patients compared to controls, thus replicating the findings of Arinami et al.6 These results strongly suggest that the MTHFR gene is involved in the pathogenesis of schizophrenia characterized by a rapid and sustained therapeutic response to typical neuroleptics and/or a good long-term prognosis/favorable therapeutic outcome.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Tsuang MT, Lyons MJ, Faraone SV . Heterogeneity of schizophrenia. Conceptual models and analytic strategies Br J Psychiatry 1990; 156: 17–26

    Article  CAS  Google Scholar 

  2. Szymanski S, Lieberman JA, Alvir JM, Mayerhoff D, Loebel A, Geisler S et al. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients Am J Psychiatry 1995; 152: 698–703

    Article  CAS  Google Scholar 

  3. Breier A, Schreiber JL, Dyer J, Pickar D . National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome Arch Gen Psychiatry 1991; 48: 239–246

    Article  CAS  Google Scholar 

  4. Tsuang MT, Lyons MJ, Faraone SV . Heterogeneity of schizophrenia. Conceptual models and analytic strategies Br J Psychiatry 1990; 156: 17–26

    Article  CAS  Google Scholar 

  5. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase [letter] Nat Genet 1995; 10: 111–113

    Article  CAS  Google Scholar 

  6. Arinami T, Yamada N, Yamakawa-Kobayashi K, Hamaguchi H, Toru M . Methylenetetrahydrofolate reductase variant and schizophrenia/depression Am J Med Genet 1997; 74: 526–528

    Article  CAS  Google Scholar 

  7. Christensen B, Frosst P, Lussier-Cacan S, Selhub J, Goyette P, Rosenblatt DS et al. Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease Arterio Thromb Vasc Biol 1997; 17: 569–573

    Article  CAS  Google Scholar 

  8. Bakker RC, Brandjes DP . Hyperhomocysteinaemia and associated disease Pharm World Sci 1997; 19: 126–132

    Article  CAS  Google Scholar 

  9. Grandone E, Margaglione M, Colaizzo D, d'Addedda M, D'Andrea G, Pavone G et al. Methylene tetrahydrofolate reductase (MTHFR) 677T→C mutation and unexplained early pregnancy loss [letter] Thrombosis & Haemostasis 1998; 79: 1056–1057

    CAS  Google Scholar 

  10. Regland B, Johansson BV, Grenfeldt B, Hjelmgren LT, Medhus M . Homocysteinemia is a common feature of schizophrenia J Neural Transm – Gen Sect 1995; 100: 165–169

    Article  CAS  Google Scholar 

  11. Regland B, Johansson BV, Gottfries CG . Homocysteinemia and schizophrenia as a case of methylation deficiency J Neural Transm – Gen Sect 1994; 98: 143–152

    Article  CAS  Google Scholar 

  12. Pasquier F, Lebert F, Petit H, Zittoun J, Marquet J . Methylenetetrahydrofolate reductase deficiency revealed by a neuropathy in a psychotic adult [letter] J Neurol Neurosurg Psychiatry 1994; 57: 765–766

    Article  CAS  Google Scholar 

  13. Freeman JM, Finkelstein JD, Mudd SH . Folate-responsive homocystinuria and ‘schizophrenia’. A defect in methylation due to deficient 5, 10-methylenetetrahydrofolate reductase activity N Engl J Med 1975; 292: 491–496

    Article  CAS  Google Scholar 

  14. Grieco AJ . Homocystinuria: pathogenetic mechanisms Am J Med Sci 1977; 273: 120–132

    Article  CAS  Google Scholar 

  15. Gudnason V, Stansbie D, Scott J, Bowron A, Nicaud V, Humphries S . C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentration in different European populations. EARS group Atherosclerosis 1998; 136: 347–354

    Article  CAS  Google Scholar 

  16. Dalman C, Allebeck P, Cullberg J, Grunewald C, Koster M . Obstetric complications and the risk of schizophrenia: a longitudinal study of a national birth cohort Arch Gen Psychiatry 1999; 56: 234–240

    Article  CAS  Google Scholar 

  17. Wyatt RJ . Neuroleptics and the natural course of schizophrenia Schizophr Bull 1991; 17: 325–351

    Article  CAS  Google Scholar 

  18. Joober R, Benkelfat C, Toulouse A, Lafrenière RG, Lal S, Ajroud S et al. Analysis of 14 CAG repeat-containing genes in schizophrenia Am J Med Genet 1999; 88: 694–699

    Article  CAS  Google Scholar 

  19. Kane J, Honigfeld G, Singer J, Meltzer H . Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine Arch Gen Psychiatry 1988; 45: 789–796

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R Joober.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Joober, R., Benkelfat, C., Lal, S. et al. Association between the methylenetetrahydrofolate reductase 677C→T missense mutation and schizophrenia. Mol Psychiatry 5, 323–326 (2000). https://doi.org/10.1038/sj.mp.4000724

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4000724

Keywords

This article is cited by

Search

Quick links